The Secretary of the Department of Health and Human Services (HHS) has selected three new models for testing by the Centers for Medicare & Medicaid Services’ (C 15 February 2023
In the USA, the Department of Health and Human Services (HHS) has released its initial guidance for the implementation of a rebate program capping the price of 10 February 2023
Administrators at the US Department of Health and Human Services (HHS) have announced key dates in its planned negotiation of certain prescription drug prices a 12 January 2023
The outcome of the recent mid-term elections in the USA surprised many by returning a Democrat-led Senate, preventing Republicans from gaining control of the ne 28 November 2022
Alnylam has announced that it will not presently be taking its drug Amvuttra (vutrisiran) into a Phase III trial for Stargardt disease. 28 October 2022
Drug pricing policy changes in the USA were signed into law as part of the Inflation Reduction Act last month in one of the most impactful acts of the Biden adm 21 September 2022
US agencies the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have announced the launch of the Critical Path for Rare Neurodege 16 September 2022
American president Joe Biden has announced his intent to appoint Dr Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health (ARP 13 September 2022
The passing of the $740 billion Inflation Reduction Act.which aims to control and lower prescription drug costs.will be welcome news for patients feeling the re 24 August 2022
US Department of Health and Human Services (HHS) Secretary Xavier Becerra has announced more than $20 million in funding to expand HIV prevention, testing, and 24 August 2022
The face of the USA’s response to the coronavirus pandemic, Anthony Fauci, has announced he will step down from his role as Director of the National Institute o 23 August 2022
The US Department of Health and Human Services (HHS) has facilitated an agreement between Bavarian Nordic and Grand River Aseptic Manufacturing (GRAM) to establ 19 August 2022
As President Joe Biden signs the Inflation Reduction Act into law.drugmakers in the USA are poring over the likely impact on drug prices.and how best to respond 17 August 2022
US President Joe Biden looks set to secure a major legislative win that could affect drug pricing in the country, as the Inflation Reduction Act narrowly won Se 8 August 2022
The Pharmaceutical Research and Manufacturers of America (PhRMA).a trade group representing biopharmaceutical and biotechnology research and discovery companies 5 August 2022
Consultancy Vital Transformation has published new research showing that the Build Back Better Act (BBBA) will have a negative impact on patient access to new 28 July 2022
The Pharmaceutical Research and Manufacturers of America (PhRMA) is to oppose what it calls “flawed price-setting proposals,” arguing instead for changes to the 20 July 2022
The US medicines regulator has issued three final guidances to drugmakers regarding cancer clinical trials, reflecting a broader push from the administration to 2 March 2022
Members of the US House of Representatives have written a letter to Secretary of Health and Human Services (HHS) Xavier Becerra urging him to follow through wit 11 February 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.